Länder Analysen: Schweiz
| 17.09.21 | Swiss Re Sell | UBS AG | |
| 14.09.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 31.08.21 | Swiss Re Sell | UBS AG | |
| 27.08.21 | Clariant Underweight | JP Morgan Chase & Co. | |
| 25.08.21 | DocMorris Sell | UBS AG | |
| 20.08.21 | Givaudan Underperform | Bernstein Research | |
| 19.08.21 | DocMorris Sell | UBS AG | |
| 17.08.21 | Swiss Re Sell | UBS AG | |
|
Werbung
|
|||
| 10.08.21 | Givaudan Underweight | Barclays Capital | |
| 02.08.21 | Swiss Re Sell | UBS AG | |
| 29.07.21 | Clariant Underweight | JP Morgan Chase & Co. | |
| 28.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 23.07.21 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley | |
| 22.07.21 | Givaudan Underperform | Bernstein Research | |
| 22.07.21 | Givaudan Underperform | Jefferies & Company Inc. | |
| 22.07.21 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
| 21.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.07.21 | UBS Underweight | Barclays Capital | |
| 20.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.07.21 | UBS Underweight | Barclays Capital | |
| 06.07.21 | UBS Underweight | Barclays Capital | |
| 07.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 07.07.21 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
| 29.06.21 | Givaudan Underperform | Jefferies & Company Inc. | |
| 25.06.21 | DocMorris Sell | UBS AG | |
| 17.06.21 | DocMorris Sell | UBS AG | |
| 17.06.21 | Givaudan Underperform | Bernstein Research | |
| 07.06.21 | Givaudan Underperform | Credit Suisse Group | |
| 04.06.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.05.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.05.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 18.05.21 | DocMorris Sell | UBS AG | |
| 18.05.21 | Givaudan Underweight | Barclays Capital | |
| 10.05.21 | Swiss Re Sell | UBS AG | |
| 30.04.21 | UBS Underweight | Barclays Capital | |
| 28.04.21 | Novartis Underweight | Barclays Capital | |
| 28.04.21 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 28.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.21 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley | |
| 27.04.21 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley | |
| 27.04.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 27.04.21 | UBS Underweight | Barclays Capital | |
| 27.04.21 | DocMorris Sell | UBS AG | |
| 27.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.04.21 | Novartis Underweight | Barclays Capital | |
| 22.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.04.21 | DocMorris Sell | UBS AG | |
| 21.04.21 | UBS Underweight | Barclays Capital | |
| 16.04.21 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 16.04.21 | Givaudan Underperform | Jefferies & Company Inc. | |